Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Cardiovasc Echogr ; 26(3): 100-103, 2016.
Article in English | MEDLINE | ID: mdl-28465972

ABSTRACT

Double-orifice mitral valve (DOMV) is a very rare congenital anomaly that usually presents as mitral regurgitation. We present the case of a 39-year-old asymptomatic, healthy man with no previous medical history who was affected by isolated complete bridge type DOMV, incidentally detected by two-dimensional echocardiographic examination in the parasternal short-axis view. The mitral valve of the patient was normally functioning without any other coexistent cardiac abnormalities. Isolated DOMV was also confirmed by cardiac magnetic resonance imaging. The patient is now followed up to detect possible complications.

2.
Int J Cardiol ; 148(3): 271-5, 2011 May 05.
Article in English | MEDLINE | ID: mdl-19948365

ABSTRACT

BACKGROUND: A prolonged total isovolumic time (T-IVT) has been shown to be associated with worsening survival in patients submitted to coronary artery surgery. However, it is not known whether it has prognostic significance in patients with chronic systolic heart failure (HF). AIM: To determine the prognostic value of T-IVT in comparison with other clinical, biochemical and echocardiographic variables in patients with chronic systolic HF. METHODS: Patients (n=107; age 68±12 years, 25% women) with chronic systolic HF, left ventricular ejection fraction (EF)<45%, and sinus rhythm, underwent a complete Doppler echocardiographic study, that included tissue Doppler long axis velocities and total isovolumic time (T-IVT), determined as [60-(total ejection time+total filling time)]. Plasma N-terminal pro-B natriuretic peptide (NT-pro-BNP) was also measured. The associations of dichotomous variables selected according to the Receiver Operator Characteristic analysis were assessed using the Cox proportional hazard model. RESULTS: Follow-up period was 37±18 months. Multivariate predictors of events were T-IVT≥12.3% s/min, mean E/Em ratio≥10, log NT-pro-BNP levels≥2.47 pg/ml and LV EF≤32.5%. On Kaplan-Meier analysis, patients with prolonged T-IVT, high mean E/Em ratio, increased NT-pro-BNP levels and decreased LV EF had a worse outcome compared with those without. The addition of T-IVT and NT-pro-BNP to conventional clinical and echocardiographic variables significantly improved the chi-square for the prediction of the outcome from 33.1 to 38.0, (P<0.001). CONCLUSIONS: Prolonged T-IVT added to the prognostic stratification of patients with systolic HF.


Subject(s)
Echocardiography, Doppler/standards , Heart Failure, Systolic/diagnostic imaging , Stroke Volume/physiology , Ventricular Dysfunction, Left/diagnostic imaging , Ventricular Function, Left/physiology , Aged , Aged, 80 and over , Female , Follow-Up Studies , Heart Failure, Systolic/physiopathology , Humans , Male , Middle Aged , Predictive Value of Tests , Prognosis , Prospective Studies , Ventricular Dysfunction, Left/physiopathology
3.
Eur J Echocardiogr ; 11(4): 333-40, 2010 May.
Article in English | MEDLINE | ID: mdl-20051423

ABSTRACT

AIMS: This study was designed to ascertain whether the combination of Doppler assessment of the ratio of mitral blood flow to myocardial early diastolic velocities (E/E(m) ratio) and plasma N-terminal pro-type B natriuretic peptide (NT-proBNP) testing is useful to better stratify patients with stable systolic heart failure (HF). METHODS AND RESULTS: A total of 362 outpatients with chronic systolic HF (left ventricular ejection fraction or=12), 77% in those with the E/E(m) ratio in the intermediate third, and 86% in those with the E/E(m) ratio in the lower third (

Subject(s)
Heart Failure, Systolic/blood , Heart Failure, Systolic/diagnostic imaging , Adult , Aged , Aged, 80 and over , Biomarkers/blood , Blood Flow Velocity , Echocardiography, Doppler , Female , Heart Failure, Systolic/mortality , Humans , Male , Middle Aged , Natriuretic Peptide, Brain/blood , Peptide Fragments/blood , Risk Assessment/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...